Neuroflow

Neuroflow was founded in 2016 by Christopher Molaro and Adam Pardes. Molaro served as a US Army officer before attending Wharton, where he observed that behavioral health lacked the remote monitoring tools standard in diabetes or cardiac care. The thesis was that payers and integrated health systems would eventually require objective, continuous mental-health data to manage risk — the same way labs and vitals drive decisions in physical medicine.

No. Neuroflow is a software company, not a care provider. It does not employ therapists, psychiatrists, or social workers, and it does not bill for clinical services. Its platform aggregates patient-reported outcomes, device data, and claims signals into dashboards and risk scores that existing clinical teams use to triage and monitor behavioral health.

Neuroflow holds at least one known contract with the US Department of Veterans Affairs, the largest integrated behavioral health provider in the country. The VA began deploying Neuroflow's platform to monitor mental health risk across its network, and a 2023 contract expansion signaled broader roll-out across additional VA medical centers (per VA public contracting records, October 2023).

Neuroflow has raised approximately $55 million in disclosed venture funding. Known backers include Concord Health Partners, SEMCAP Health, and Cigna Ventures — the venture arm of the health insurer Cigna — which participated in a 2021 funding round. The presence of a strategic payer investor signals alignment with insurer-driven behavioral health integration initiatives.

Neuroflow sells enterprise software licenses to health systems, payers, and government agencies — primarily in the United States. The platform is typically priced on a per-member-per-month or per-seat SaaS model. Revenue scales with the number of covered lives under contract rather than fee-for-service clinical volume, aligning the company's growth with payer contracts, not patient visits.